热景生物：2025年前三季度净利润约-1.09亿元

Core Viewpoint - The company reported a significant decline in revenue and incurred a net loss in the third quarter of 2023, indicating potential challenges in its financial performance moving forward [1]. Financial Performance - For the first three quarters of 2023, the company's revenue was approximately 310 million yuan, representing a year-on-year decrease of 19.8% [1]. - The net profit attributable to shareholders of the listed company was a loss of approximately 109 million yuan [1]. Market Position - As of the report date, the company's market capitalization stood at 15.3 billion yuan [2].